KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) Debt to Equity (2020 - 2026)

Organon has reported Debt to Equity over the past 7 years, most recently at $9.49 for Q1 2026.

  • For Q1 2026, Debt to Equity fell 42.57% year-over-year to $9.49; the TTM value through Mar 2026 reached $9.49, down 42.57%, while the annual FY2025 figure was $11.49, 38.9% down from the prior year.
  • Debt to Equity for Q1 2026 was $9.49 at Organon, down from $11.49 in the prior quarter.
  • Over five years, Debt to Equity peaked at $181.54 in Q1 2024 and troughed at -$125.14 in Q4 2023.
  • A 5-year average of $8.06 and a median of $9.49 in 2026 define the central range for Debt to Equity.
  • Biggest five-year swings in Debt to Equity: plummeted 2360.1% in 2022 and later surged 1635.95% in 2024.
  • Year by year, Debt to Equity stood at -$9.99 in 2022, then tumbled by 1152.41% to -$125.14 in 2023, then skyrocketed by 115.03% to $18.81 in 2024, then tumbled by 38.9% to $11.49 in 2025, then decreased by 17.44% to $9.49 in 2026.
  • Business Quant data shows Debt to Equity for OGN at $9.49 in Q1 2026, $11.49 in Q4 2025, and $9.74 in Q3 2025.